Mechanism-based therapy of non-cardiac syncope : a practical guide
(2024) In Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology- Abstract
The term non-cardiac syncope includes all forms of syncope, in which primary intrinsic cardiac mechanism and non-syncopal transient loss of consciousness can be ruled out. Reflex syncope and orthostatic hypotension are the most frequent etiologies of non-cardiac syncope. As no specific therapy is effective for all types of non-cardiac syncope, identifying the underlying hemodynamic mechanism is the essential prerequisite for an effective personalized therapy and prevention of syncope recurrences. Indeed, choice of appropriate therapy and its efficacy are largely determined by the syncope mechanism rather than its etiology and clinical presentation. The two main hemodynamic phenomena leading to non-cardiac syncope include either profound... (More)
The term non-cardiac syncope includes all forms of syncope, in which primary intrinsic cardiac mechanism and non-syncopal transient loss of consciousness can be ruled out. Reflex syncope and orthostatic hypotension are the most frequent etiologies of non-cardiac syncope. As no specific therapy is effective for all types of non-cardiac syncope, identifying the underlying hemodynamic mechanism is the essential prerequisite for an effective personalized therapy and prevention of syncope recurrences. Indeed, choice of appropriate therapy and its efficacy are largely determined by the syncope mechanism rather than its etiology and clinical presentation. The two main hemodynamic phenomena leading to non-cardiac syncope include either profound hypotension or extrinsic asystole/pronounced bradycardia, corresponding to two different hemodynamic syncope phenotypes, the hypotensive and bradycardic phenotype. The choice of therapy - aimed at counteracting hypotension or bradycardia - depends on the given phenotype. Discontinuation of blood pressure lowering drugs, elastic garments, and blood pressure elevating agents such as fludrocortisone and midodrine are the most effective therapies in patients with hypotensive phenotype. Cardiac pacing, cardioneuroablation, and drugs preventing bradycardia such as theophylline are the most effective therapies in patients with bradycardic phenotype of extrinsic cause.
(Less)
- author
- Brignole, Michele ; Rivasi, Giulia and Fedorowski, Artur LU
- publishing date
- 2024-03-26
- type
- Contribution to journal
- publication status
- epub
- in
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
- publisher
- Oxford University Press
- external identifiers
-
- pmid:38529800
- scopus:85189788307
- ISSN
- 1532-2092
- DOI
- 10.1093/europace/euae073
- language
- English
- LU publication?
- no
- additional info
- © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
- id
- 66b963bf-bb1b-4c3b-bac7-197210532c2f
- date added to LUP
- 2024-04-01 19:45:41
- date last changed
- 2024-08-04 15:00:39
@article{66b963bf-bb1b-4c3b-bac7-197210532c2f, abstract = {{<p>The term non-cardiac syncope includes all forms of syncope, in which primary intrinsic cardiac mechanism and non-syncopal transient loss of consciousness can be ruled out. Reflex syncope and orthostatic hypotension are the most frequent etiologies of non-cardiac syncope. As no specific therapy is effective for all types of non-cardiac syncope, identifying the underlying hemodynamic mechanism is the essential prerequisite for an effective personalized therapy and prevention of syncope recurrences. Indeed, choice of appropriate therapy and its efficacy are largely determined by the syncope mechanism rather than its etiology and clinical presentation. The two main hemodynamic phenomena leading to non-cardiac syncope include either profound hypotension or extrinsic asystole/pronounced bradycardia, corresponding to two different hemodynamic syncope phenotypes, the hypotensive and bradycardic phenotype. The choice of therapy - aimed at counteracting hypotension or bradycardia - depends on the given phenotype. Discontinuation of blood pressure lowering drugs, elastic garments, and blood pressure elevating agents such as fludrocortisone and midodrine are the most effective therapies in patients with hypotensive phenotype. Cardiac pacing, cardioneuroablation, and drugs preventing bradycardia such as theophylline are the most effective therapies in patients with bradycardic phenotype of extrinsic cause.</p>}}, author = {{Brignole, Michele and Rivasi, Giulia and Fedorowski, Artur}}, issn = {{1532-2092}}, language = {{eng}}, month = {{03}}, publisher = {{Oxford University Press}}, series = {{Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology}}, title = {{Mechanism-based therapy of non-cardiac syncope : a practical guide}}, url = {{http://dx.doi.org/10.1093/europace/euae073}}, doi = {{10.1093/europace/euae073}}, year = {{2024}}, }